Diabetes and Cardiovascular Disease Following Kidney Transplantation

Boerner, Brian P.; Shivaswamy, Vijay; Desouza, Cyrus V.; Larsen, Jennifer L.
July 2011
Current Diabetes Reviews;Jul2011, Vol. 7 Issue 4, p221
Academic Journal
Kidney transplantation is being performed more frequently for individuals with end stage renal disease (ESRD) due to improved survival and quality of life compared to long-term dialysis. Though rates decrease after transplant, cardiovascular disease (CVD) remains the most common cause of death after kidney transplant. New-onset diabetes after transplant (NODAT), a common complication following kidney transplantation, and pre-transplant diabetes both significantly increase the risk for CVD. Several other risk factors for CVD in kidney transplant recipients have been identified; however, optimal therapy for controlling the risk factors of CVD after kidney transplantation, including NODAT and pre-transplant diabetes, is not well defined. In the following review we will discuss the role of traditional and non-traditional risk factors in CVD after kidney transplant and the mechanisms involved therein. We will also examine the current literature regarding treatment of these risk factors for the prevention of CVD. Finally, we will review the current recommendations for pre- and post-transplant cardiovascular evaluation and management.


Related Articles

  • COPING WITH CHRONIC KIDNEY DISEASE. Magill-Lewis, Jillene // Drug Topics;9/27/2004, Vol. 148 Issue 18, pHSE21 

    This article states that the rise in obesity in the United States has led to an increased incidence of diabetes, the leading cause of chronic kidney disease (CKD). The two primary results of CKD are loss of kidney function and the development of cardiovascular disease. The National Kidney...

  • The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Gill, J. S.; Rose, C.; Pereira, B. J. G.; Tonelli, M. // Kidney International;Mar2007, Vol. 71 Issue 5, p442 

    Analyses describing outcomes of kidney transplantation usually exclude the survival of wait-listed patients and dialysis patients with failed kidney transplants, and thus reflect only a portion of the typical transplant process. We determined death rates during the continuum of wait-listing,...

  • Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR. Dere, Ruhee; Wilson, Patricia D.; Sandford, Richard N.; Walker, Cheryl Lyn // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited renal disorder caused by defects in the PKD1 or PKD2 genes. ADPKD is associated with significant morbidity, and is a major underlying cause of end-stage renal failure (ESRF). Commonly, treatment options are limited to...

  • Enhanced posttransplant management of patients with diabetes improves patient outcomes. Keddis, Mira T; El Ters, Mireille; Rodrigo, Emilio; Dean, Patrick; Wohlfahrtova, Mariana; Kudva, Yogish C; Lorenz, Elizabeth C; Cosio, Fernando G // Kidney International;Sep2014, Vol. 86 Issue 3, p610 

    The survival of patients with diabetes mellitus in the general population has improved in recent years. Here we assessed whether similar trends have occurred in 1688 kidney recipients, including 413 with diabetes prior to transplant between 1996 and 2007. Compared to patients without diabetes,...

  • Podocytopenia, parietal epithelial cells and glomerulosclerosis. Berger, Katja; Moeller, Marcus J. // Nephrology Dialysis Transplantation;May2014, Vol. 29 Issue 5, p948 

    No abstract available.

  • Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Cosio, Fernando G.; Pesavento, Todd E.; Kim, Sunny; Osei, Kwame; Henry, Mitchell; Ferguson, Ronald M. // Kidney International;Oct2002, Vol. 62 Issue 4, p1440 

    Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Background. The development of de novo diabetes mellitus is a serious complication of kidney transplantation. This study examined the cardiovascular risk profile of patients with post-transplant diabetes (PTDM)...

  • Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Adedayo, Ajibola; Olafiranye, Oladipupo; Smith, David; Hill, Alethea; Zizi, Ferdinand; Brown, Clinton; Jean-Louis, Girardin // Sleep & Breathing;Mar2014, Vol. 18 Issue 1, p13 

    Introduction: Over the past half century, evidence has been accumulating on the emergence of obstructive sleep apnea (OSA), the most prevalent sleep-disordered breathing, as a major risk factor for cardiovascular disease. A significant body of research has been focused on elucidating the complex...

  • Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes. De Berardis, Giorgia; Lucisano, Giuseppe; D'Ettorre, Antonio; Pellegrini, Fabio; Lepore, Vito; Tognoni, Gianni; Nicolucci, Antonio // JAMA: Journal of the American Medical Association;6/6/2012, Vol. 307 Issue 21, p2286 

    The article discuses the association of aspirin use with major bleeding in patients with and without diabetes. It informs that aspirin is used for the treatment of cardiovascular disease and is generally recommended as a secondary prevention measure for individuals with moderate to high risk of...

  • Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland.  // BMC Public Health;2012, Vol. 12 Issue 1, p246 

    The article presents the findings of a research conducted on examining the regional differences in self-reported screening, prevalence, and management of cardiovascular risk factors in Switzerland. It discusses the methodology of the research. It concludes that cardiovascular risk factor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics